There is an urgent need for more inclusive and community-focused cancer clinical trials, according to Kimberly (Cary) ...

Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.

Mariam Eskander, MD, explores how food insecurity and geographic barriers hinder breast cancer trial participation, ...

Experts are calling for tailored strategies to enhance the diagnosis, treatment, and monitoring of older people with multiple ...

PharmAla Biotech Holdings Inc. ('PharmAla” or the 'Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the ...

A new study reveals that swapping a typical nighttime carbohydrate snack for pistachios may beneficially alter gut bacteria ...

It will be piloted in Cambridge on the PemOla trial, a precision medicine study exploring a combination immunotherapy, using ...

Unpredictable FDA and funding woes delay crucial drug approvals, depriving thousands of patients access to vital treatments ...

Peanuts are one of the main allergies among children, but new research shows that introducing peanuts early can reduce the ...

As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer ...

Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...